These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 19995409)
41. Increased leukocyte-platelet interactions during circulatory support with left ventricular assist devices. Radovancevic R; Matijevic N; Bracey AW; Radovancevic B; Elayda M; Gregoric ID; Frazier OH ASAIO J; 2009; 55(5):459-64. PubMed ID: 19730003 [TBL] [Abstract][Full Text] [Related]
42. Enhanced Fcgamma receptor I, alphaMbeta2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: interaction with platelets. Bunescu A; Seideman P; Lenkei R; Levin K; Egberg N J Rheumatol; 2004 Dec; 31(12):2347-55. PubMed ID: 15570633 [TBL] [Abstract][Full Text] [Related]
43. Increased platelet-monocyte aggregates and cardiovascular disease in end-stage renal failure patients. Ashman N; Macey MG; Fan SL; Azam U; Yaqoob MM Nephrol Dial Transplant; 2003 Oct; 18(10):2088-96. PubMed ID: 13679485 [TBL] [Abstract][Full Text] [Related]
44. Platelet and leukocyte activation, atherosclerosis and inflammation in European and South Asian men. Dotsenko O; Chaturvedi N; Thom SA; Wright AR; Mayet J; Shore A; Schalkwijk C; Hughes AD J Thromb Haemost; 2007 Oct; 5(10):2036-42. PubMed ID: 17883700 [TBL] [Abstract][Full Text] [Related]
45. Characterization of platelet and soluble-porcine P-selectin (CD62P). Massaguer A; Engel P; Tovar V; March S; Rigol M; Solanes N; Bosch J; Pizcueta P Vet Immunol Immunopathol; 2003 Dec; 96(3-4):169-81. PubMed ID: 14592730 [TBL] [Abstract][Full Text] [Related]
46. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation. Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960 [TBL] [Abstract][Full Text] [Related]
47. Platelet and leukocyte activation correlate with the severity of septic organ dysfunction. Russwurm S; Vickers J; Meier-Hellmann A; Spangenberg P; Bredle D; Reinhart K; Lösche W Shock; 2002 Apr; 17(4):263-8. PubMed ID: 11954824 [TBL] [Abstract][Full Text] [Related]
48. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Jensen MK; de Nully Brown P; Lund BV; Nielsen OJ; Hasselbalch HC Eur J Haematol; 2001 Mar; 66(3):143-51. PubMed ID: 11350482 [TBL] [Abstract][Full Text] [Related]
49. Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes. Villmow T; Kemkes-Matthes B; Matzdorff AC Thromb Res; 2002 Nov; 108(2-3):139-45. PubMed ID: 12590950 [TBL] [Abstract][Full Text] [Related]